News & Updates

Cyclosporin may increase malignancy risk in psoriasis
Cyclosporin may increase malignancy risk in psoriasis
07 Dec 2022

In psoriasis patients, treatment with cyclosporin may increase the risk of malignancy without nonmelanoma skin cancer, a recent study has found. Biologic or phototherapy have no such impact.

Cyclosporin may increase malignancy risk in psoriasis
07 Dec 2022
Erenumab works well in chronic migraine patients across Asia
Erenumab works well in chronic migraine patients across Asia
06 Dec 2022 byJairia Dela Cruz

Erenumab proves to be effective at lowering the number of monthly migraine days in Asian patients with chronic migraine while having a favourable safety profile, according to the results of DRAGON study.

Erenumab works well in chronic migraine patients across Asia
06 Dec 2022